FdaApplication
ANDA 217652
Identifiers
- fda_app_no: ANDA217652
Properties
| Property | Value |
|---|---|
| applicant_name | GRAVITI PHARMACEUTICALS PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2023-08-17 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET;ORAL |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 50MG | TABLET;ORAL |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET;ORAL |
3 products